pansion Revenue after Phase 2b/3 Shingles trial & Ph 2 EBV-transplant may be possible as part of Named Patient Programs MI a 20 EFTA00506089 Valomaciclovir Stearate (EPB-348) Second Indication: Epstein-Barr Virus (EBV) & Transplant 11 __ IIIIIIIIII 21 EFTA00506090 EPB-348 has already demonstrated human cli